APA (7th ed.) Citation

Weller, M., & Wick, W. (2017). Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - authors' reply. The lancet. Oncology, 18(12), . https://doi.org/10.1016/S1470-2045(17)30856-2

Chicago Style (17th ed.) Citation

Weller, Michael, and Wolfgang Wick. "Go, No-go Decision Making for Phase 3 Clinical Trials: ACT IV Revisited - Authors' Reply." The Lancet. Oncology 18, no. 12 (2017). https://doi.org/10.1016/S1470-2045(17)30856-2.

MLA (9th ed.) Citation

Weller, Michael, and Wolfgang Wick. "Go, No-go Decision Making for Phase 3 Clinical Trials: ACT IV Revisited - Authors' Reply." The Lancet. Oncology, vol. 18, no. 12, 2017, https://doi.org/10.1016/S1470-2045(17)30856-2.